「by」の検索結果
75件：46～50件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
ociety and medical care occur with increasing speed. In these difficult times, we stand steadfastly by our values and continue to be a company that acts on them as we look forward to meeting future ch...
https://www.senju.co.jp/english/about/message.html -
shida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; here...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
onsumers and patients. The role of the Center is to contribute to the proper use of pharmaceuticals by promptly and conscientiously providing customers with useful information about all our company�...
https://www.senju.co.jp/english/about/csr01.html -
huhei Yoshida; hereinafter: Senju) is developing a compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; here...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
Mytear PINT CARE EX | OTC Products, etc. | Products | SENJU Pharmaceutical
sician, pharmacist, or registered salesperson** before using this medicine: Persons under treatment by a physician Persons who have had allergies to medicines or something Persons who have suffered fr...
http://www.senju.co.jp/english/products/mytearpintcare.html